| General information | Literature | Expression | Regulation | Mutation | Interaction |
|
Basic Information |
|
|---|---|
Gene ID | 84735 |
Name | CNDP1 |
Synonymous | CN1|CPGL2|HsT2308;carnosine dipeptidase 1 (metallopeptidase M20 family);CNDP1;carnosine dipeptidase 1 (metallopeptidase M20 family) |
Definition | CNDP dipeptidase 1|beta-Ala-His dipeptidase|carnosinase 1|glutamate carboxypeptidase-like protein 2|serum carnosinase |
Position | 18q22.3 |
Gene type | protein-coding |
Source | Count: CNDP1; 18q22.3 |
|
Sentence |
Abstract |
| "We detected a significant association at the CBLN2 locus mapping to 18q22.3, with the risk allele conferring an odds ratio for PAH of 1.97 (1.59-2.45; P = 7.47 � 10-10)." | pulmonary arterial hypertension (PAH) is a rare, severe disease resulting from progressive obliteration of small-caliber pulmonary arteries by proliferating vascular cells. PAH can occur without recognized etiology (idiopathic PAH), be associated with a systemic disease or occur as a heritable form, with BMPR2 mutated in approximately 80% of familial and 15% of idiopathic PAH cases. We conducted a genome-wide association study (GWAS) based on 2 independent case-control studies for idiopathic and familial PAH (without BMPR2 mutations), including a total of 625 cases and 1,525 healthy individuals. We detected a significant association at the CBLN2 locus mapping to 18q22.3, with the risk allele conferring an odds ratio for PAH of 1.97 (1.59-2.45; P = 7.47 x 10-10). CBLN2 is expressed in the lung, and its expression is higher in explanted lungs from individuals with PAH and in endothelial cells cultured from explanted PAH lungs. |